MiniMed (MMED) announced Health Canada has licensed new software for the MiniMed 780G system. Additionally, the system is now compatible with Fiasp and indicated for adults 18 years and older with Type 2 diabetes.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MMED:
- Medtronic price target lowered to $95 from $108 at Jefferies
- William Blair med tech analyst holds an analyst/industry conference call
- Medtronic price target lowered to $95 from $105 at Stifel
- Goldman Sachs Says Markets Stay Strong – Picks 2 ‘Strong Buy’ Stocks to Consider
- MiniMed initiated with a Buy at Deutsche Bank